First Trust Advisors’s Kite Pharma, Inc. KITE Stock Holding History

First Trust Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-416,224	Closed	-$74.8M	–	2529
2017 Q3	$74.8M	Sell	416,224 -60,728	-13%	-$8.46M	0.19%	111
2017 Q2	$49.4M	Sell	476,952 -133,620	-22%	-$10.9M	0.13%	172
2017 Q1	$47.9M	Buy	610,572 +3,300	+0.5%	+$204K	0.13%	150
2016 Q4	$27.2M	Buy	607,272 +594,715	+4,736%	+$29.2M	0.08%	320
2016 Q3	$701K	Buy	+12,557	New	+$700K	﹤0.01%	1876

First Trust Advisors's KITE Position: Q4 2017 in Review

First Trust Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 416,224 shares — an estimated $74.8M sold.

First Trust Advisors first reported a position in KITE in Q3 2016 and held it in 5 quarters. The position peaked at $74.8M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

First Trust Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
First Trust Advisors sold 416,224 Kite Pharma, Inc. shares in Q4 2017, an estimated $74.8M.
First Trust Advisors first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 5 quarters.
First Trust Advisors's Kite Pharma, Inc. position peaked at $74.8M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on First Trust Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.